Category: Regulatory DisclosuresBy adminMarch 18, 2024 Author: admin https://ramedapharma-ir.com Post navigationPreviousPrevious post:Annual Corporate Governance Disclosure ReportNextNext post:Rameda 4Q23 BOD Meeting MinutesRelated PostsBOD-Shareholding-Structure-2024April 15, 2024The invitation to shareholders for the AGMMarch 31, 2024RetractionMarch 24, 2024Rameda 4Q23 BOD Meeting MinutesMarch 18, 2024Annual Corporate Governance Disclosure ReportMarch 18, 2024Rameda 4Q23 BOD Meeting MinutesMarch 18, 2024
